News
Learn how the region's strengths in polymer research and innovation have been crucial to Warwick Spinout Medherant's development of cutting-edge transdermal drug delivery solutions.
A big step forward for Interface Polymers Ltd
Warwick Chemistry spinout Interface Polymers Ltd (IPL) announces a ground-breaking achievement – the commercial scale-up of their first product. More at tinyurl.com/3ebkt6uh
Science labs opened to support students from Aylesford School
Aylesford Sixth Form Science students welcomed to complete practical exams and gain hands-on experience in our labs following classroom closures. More at tinyurl.com/mr4d4hpr
Times Higher Education covers Warwick鈥檚 spin-out company, t, and Prof Dave Haddleton's aim to launch a testosterone patch for menopausal women.
Towards universal software for quantum dynamics simulations
Prof. Scott Habershon receives a share of EPSRC funding for COSMOS - a major project to create a universal software framework for quantum dynamics simulations with UCL.
Graphene discovery could help generate hydrogen cheaply and sustainably
Researchers from Warwick and Manchester finally solve long-standing puzzle of why graphene is so much more permeable to protons than expected by theory.
New RSC video explains 'Team Ice's' award-winning research
The work of 'Team Ice' has been brought to life in a new RSC-commissioned videoLink opens in a new window celebrating their Chemistry Biology Interface Division Horizon Prize, 2022.
GC Ventures is the latest investor in Interface Polymers, a developer of high-performance additives for performance plastics to enhance recyclability properties.
Spotlight on Newton Fund Research at Warwick
A Warwick case study, "Advanced materials for future energy and environmental applications in Indonesia" features in a British Council e-book highlighting innovative and collaborative Newton Fund funded research.
New discovery stops bacterial virus contamination
A new discovery by researchers at the 神马福利影片 could help stop bacteria being contaminated with viruses, reducing disruption and decreasing costs in industry and research. Read moreLink opens in a new window
Medherant to develop world鈥檚 only testosterone patch for menopause
A company born out of ground-breaking research at Warwick has raised millions to develop a testosterone patch for people suffering from low libido and reduced zest for life due to the menopause. Read moreLink opens in a new window
Evonik has invested in Warwick Chemistry spinout company, Interface Polymers Ltd. Its technology simplifies the processing of mixed plastics and also their recycling. .